MDT discussions on the rationale for using GLP-1 as a therapeutic target in T2D

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team review the rationale for using GLP-1 as a therapeutic target in T2D and provide an overview of GLP-1 RA based therapies  The multidisciplinary team Primary Care Physician: Dr Kevin Fernando, Berwick, UK Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/